These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8621175

  • 1. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA, Xie H, Wright KN, Hornbuckle WE, Gerin JL, Tennant BC, Hostetler KY.
    Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Li DH, Brown C, Eisenberg EJ, Cundy KC, Wolfe J, Toole J, Gibbs C.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2740-5. PubMed ID: 11557463
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
    Tencza MG, Newbold JE.
    J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis.
    D'Ugo E, Canitano A, Catone S, Argentini C, Giuseppetti R, Orobello S, Palmieri G, Rapicetta M.
    Arch Virol; 2008 Jan; 153(11):2069-76. PubMed ID: 18985276
    [Abstract] [Full Text] [Related]

  • 9. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    D'Ugo E, Kondili LA, Canitano A, Catone S, Giuseppetti R, Gallinella B, Palmieri G, Orobello S, Argentini C, Glück R, Rapicetta M.
    Vaccine; 2007 Jun 21; 25(26):4895-902. PubMed ID: 17531355
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC, Korba BE.
    Hepatology; 2001 Jan 21; 33(1):254-66. PubMed ID: 11124844
    [Abstract] [Full Text] [Related]

  • 11. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
    Michalak TI, Zhang H, Churchill ND, Larsson T, Johansson NG, Oberg B.
    Antimicrob Agents Chemother; 2009 Sep 21; 53(9):3803-14. PubMed ID: 19564357
    [Abstract] [Full Text] [Related]

  • 12. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
    Coffin CS, Pham TN, Mulrooney PM, Churchill ND, Michalak TI.
    Hepatology; 2004 Nov 21; 40(5):1053-61. PubMed ID: 15382154
    [Abstract] [Full Text] [Related]

  • 13. The role of the woodchuck model in the treatment of hepatitis B virus infection.
    Kulkarni K, Jacobson IM, Tennant BC.
    Clin Liver Dis; 2007 Nov 21; 11(4):707-25, vii. PubMed ID: 17981226
    [Abstract] [Full Text] [Related]

  • 14. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, Cecchi A, Linsey D, Linzey D, Frick L, Paff MT, Goulding A, Biron K.
    Antimicrob Agents Chemother; 1997 Oct 21; 41(10):2076-82. PubMed ID: 9333028
    [Abstract] [Full Text] [Related]

  • 15. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J, Gujar SA, Cova L, Michalak TI.
    J Virol; 2007 Jan 21; 81(2):903-16. PubMed ID: 17079319
    [Abstract] [Full Text] [Related]

  • 16. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.
    Colonno RJ, Genovesi EV, Medina I, Lamb L, Durham SK, Huang ML, Corey L, Littlejohn M, Locarnini S, Tennant BC, Rose B, Clark JM.
    J Infect Dis; 2001 Nov 15; 184(10):1236-45. PubMed ID: 11679911
    [Abstract] [Full Text] [Related]

  • 17. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE, Suresh M, Li B, Huang X, Yon C, Kallakury BV, Lee KP, Park S, Kim YW, Menne S.
    Cells; 2021 Sep 05; 10(9):. PubMed ID: 34571970
    [Abstract] [Full Text] [Related]

  • 18. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S, Balsitis S, Chamberlain J, Zheng J, Santos R, Rowe W, Ramakrishnan D, Pattabiraman D, Spurlock S, Chu R, Kang D, Mish M, Ramirez R, Li L, Li B, Ma S, Hung M, Voitenleitner C, Yon C, Suresh M, Menne S, Cote P, Delaney WE, Mackman R, Fletcher SP.
    Hepatology; 2021 Jan 05; 73(1):53-67. PubMed ID: 32246499
    [Abstract] [Full Text] [Related]

  • 19. Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection.
    Wang BJ, Tian YJ, Meng ZJ, Jiang M, Wei BQ, Tao YQ, Fan W, Li AY, Bao JJ, Li XY, Zhang ZM, Wang ZD, Wang H, Roggendorf M, Lu MJ, Yang DL.
    J Gen Virol; 2011 Mar 05; 92(Pt 3):681-91. PubMed ID: 21084496
    [Abstract] [Full Text] [Related]

  • 20. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2007 Sep 05; 51(9):3177-84. PubMed ID: 17606676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.